Literature DB >> 28940959

Biochemical and structural characterization of CYP109A2, a vitamin D3 25-hydroxylase from Bacillus megaterium.

Ammar Abdulmughni1, Ilona K Jóźwik2, Elisa Brill1, Frank Hannemann1, Andy-Mark W H Thunnissen2, Rita Bernhardt1.   

Abstract

Cytochrome P450 enzymes are increasingly investigated due to their potential application as biocatalysts with high regio- and/or stereo-selectivity and under mild conditions. Vitamin D3 (VD3 ) metabolites are of pharmaceutical importance and are applied for the treatment of VD3 deficiency and other disorders. However, the chemical synthesis of VD3 derivatives shows low specificity and low yields. In this study, cytochrome P450 CYP109A2 from Bacillus megaterium DSM319 was expressed, purified, and shown to oxidize VD3 with high regio-selectivity. The in vitro conversion, using cytochrome P450 reductase (BmCPR) and ferredoxin (Fdx2) from the same strain, showed typical Michaelis-Menten reaction kinetics. A whole-cell system in B. megaterium overexpressing CYP109A2 reached 76 ± 5% conversion after 24 h and allowed to identify the main product by NMR analysis as 25-hydroxylated VD3 . Product yield amounted to 54.9 mg·L-1 ·day-1 , rendering the established whole-cell system as a highly promising biocatalytic route for the production of this valuable metabolite. The crystal structure of substrate-free CYP109A2 was determined at 2.7 Å resolution, displaying an open conformation. Structural analysis predicts that CYP109A2 uses a highly similar set of residues for VD3 binding as the related VD3 hydroxylases CYP109E1 from B. megaterium and CYP107BR1 (Vdh) from Pseudonocardia autotrophica. However, the folds and sequences of the BC loops in these three P450s are highly divergent, leading to differences in the shape and apolar/polar surface distribution of their active site pockets, which may account for the observed differences in substrate specificity and the regio-selectivity of VD3 hydroxylation. DATABASE: The atomic coordinates and structure factors have been deposited in the Protein Data Bank with accession code 5OFQ (substrate-free CYP109A2). ENZYMES: Cytochrome P450 monooxygenase CYP109A2, EC 1.14.14.1, UniProt ID: D5DF88, Ferredoxin, UniProt ID: D5DFQ0, cytochrome P450 reductase, EC 1.8.1.2, UniProt ID: D5DGX1.
© 2017 Federation of European Biochemical Societies.

Entities:  

Keywords:  zzm321990Bacillus megateriumzzm321990; biocatalysis; cytochrome P450; regio-selectivity; vitamin D3

Mesh:

Substances:

Year:  2017        PMID: 28940959     DOI: 10.1111/febs.14276

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  6 in total

1.  Complete Genome Sequence of an Efficient Vitamin D3-Hydroxylating Bacterium, Pseudonocardia autotrophica NBRC 12743.

Authors:  Keitaro Yoshida; Yoshiaki Yasutake; Tomohiro Tamura
Journal:  Microbiol Resour Announc       Date:  2018-09-27

Review 2.  Bioconversion of vitamin D3 to bioactive calcifediol and calcitriol as high-value compounds.

Authors:  Zheyi Wang; Yan Zeng; Hongmin Jia; Niping Yang; Mengshuang Liu; Mingyue Jiang; Yanning Zheng
Journal:  Biotechnol Biofuels Bioprod       Date:  2022-10-13

3.  Plant growth-promoting activities and genomic analysis of the stress-resistant Bacillus megaterium STB1, a bacterium of agricultural and biotechnological interest.

Authors:  Francisco X Nascimento; Anabel G Hernández; Bernard R Glick; Márcio J Rossi
Journal:  Biotechnol Rep (Amst)       Date:  2019-12-04

4.  Manually curated genome-scale reconstruction of the metabolic network of Bacillus megaterium DSM319.

Authors:  Javad Aminian-Dehkordi; Seyyed Mohammad Mousavi; Arezou Jafari; Ivan Mijakovic; Sayed-Amir Marashi
Journal:  Sci Rep       Date:  2019-12-10       Impact factor: 4.379

5.  Investigation of Vitamin D2 and Vitamin D3 Hydroxylation by Kutzneria albida.

Authors:  Lisa Marie Schmitz; Alina Kinner; Kirsten Althoff; Katrin Rosenthal; Stephan Lütz
Journal:  Chembiochem       Date:  2021-05-04       Impact factor: 3.164

Review 6.  The "beauty in the beast"-the multiple uses of Priestia megaterium in biotechnology.

Authors:  Rebekka Biedendieck; Tobias Knuuti; Simon J Moore; Dieter Jahn
Journal:  Appl Microbiol Biotechnol       Date:  2021-07-15       Impact factor: 4.813

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.